Top NHS doctor, CEO out. Across the pond, NHS England is also seeing big changes with Sir Stephen Powis announcing his plans ...

For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access ...

Robert F Kennedy Jr's controversial views on vaccines were on display this week during an interview with CBS News in which he ...

Novartis has announced a massive investment in manufacturing and R&D facilities in the US, including seven new facilities, in ...

Since 1938, animal testing has been required by the FDA before any new drug can proceed through clinical trials and receive ...

The top-line results of the APOLLOE4 trial showed that valitramiprosate (ALZ-801) was unable to slow down cognitive decline ...

Following the success of the Boston and European editions, the ESG in Life Sciences Summit West is bringing together senior ...

Successful execution of established brand strategies requires developing specific operational capabilities. This includes developing efficient shared services, streamlined compliance processes, and ...

AKT inhibitor Truqap (capivasertib) has been cleared by NICE for use in combination with standard therapy fulvestrant for HR-positive, HER2-negative metastatic breast cancer that also has one or more ...

The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

In this webinar – ‘Enabling Digitally Enhanced Care for Rare Diseases in Europe: Integrating AI and Connected Care ...